封面
市場調查報告書
商品編碼
2058249

早洩治療市場:依藥物類型、給藥途徑、劑型、通路和地區分類。

Premature Ejaculation Treatment Market, By Drug Type, By Route of Administration, By Dosage Form, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計,2026年早洩治療市場規模為32億美元,預計2033年將達到57億美元。預計2026年至2033年,該市場將以8.9%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 32億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 8.90% 2033年市場規模預測: 57億美元

早洩,也稱為射精過快、早洩或射精過早,是指在性交過程中精液過早射出的一種疾病。雖然早洩是一個非常普遍的問題,但其確切病因尚不清楚。然而,可能的原因包括早期性經驗、性虐待、對自身形象的不滿、憂鬱症、焦慮、荷爾蒙失衡、遺傳因素、前列腺或尿道發炎或感染疾病,以及對早洩的焦慮。

市場動態

治療早洩的新產品不斷湧現,預計將推動全球早洩治療市場成長。例如,2016年,總部位於香港的投資集團Regent Pacific Group Limited在英國推出了其產品「Fortacin」。 Fortacin是一種外用噴霧劑,含有低劑量的兩種局部麻醉劑-Lidocaine和Prilocaine,用於治療早洩。此外,由於不健康的生活方式、憂鬱症和荷爾蒙失衡等多種因素,早洩的盛行率不斷上升,預計這將推動對早洩治療產品的需求。例如,根據國家生物醫藥資訊中心2016年發布的數據,中國約有25.8%的男性患有早洩。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球早洩治療市場的主要參與者進行了分析:公司概況、財務表現、產品系列、企業發展區域、分銷策略、關鍵發展和策略以及未來計劃。
  • 透過利用本報告中的見解,企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份「全球早洩治療市場報告」旨在為該行業的各種相關人員提供服務,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用分析早洩治療市場中使用的各種策略矩陣,更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • PEST分析
  • 管道分析
  • 產品核准
  • 產品發布
  • 合作關係與收購
  • 波特五力分析

第4章 全球早洩治療市場:依藥物類型分類,2021-2033年

  • 選擇性血清素再回收抑制劑(SSRIs)
  • 5型磷酸二酯酶(PDE5)抑制劑
  • 局部麻醉劑
  • 其他

第5章 全球早洩治療市場:依給藥途徑分類,2021-2033年

  • 口服
  • 外用

第6章 全球早洩治療市場:以劑型分類,2021-2033年

  • 藥片
  • 其他

第7章 全球早洩治療市場:依通路分類,2021-2033年

  • 醫院
  • 網路藥房
  • 零售藥房

第8章 全球早洩治療市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 非洲
    • 中非
    • 南非
    • 北非
  • 中東
    • GCC
    • 以色列
    • 其他中東國家

第9章 競爭情勢

  • 熱圖分析
  • 公司簡介
    • Regent Pacific Group Limited
    • Menarini Group
    • Furiex Pharmaceuticals, Inc.
    • Absorption Pharmaceuticals, LLC
    • Ampio Pharmaceuticals, Inc.
    • Aytu BioScience
    • NeuroHealing Pharmaceuticals Inc.
    • Dong-A Pharmaceutical Co., Ltd.

第10章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1956

Premature Ejaculation Treatment Market is estimated to be valued at USD 3.2 Bn in 2026 and is expected to reach USD 5.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 3.2 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 8.90% 2033 Value Projection: USD 5.7 Bn

Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.

Market Dynamics

Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.

Key features of the study

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global premature ejaculation treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technological up-gradation, market expansion, and marketing tactics
  • The global premature ejaculation treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the premature ejaculation treatment market

Market Segmentation

  • By Drug Type (Revenue, USD Bn, 2021-2033)
    • Selective Serotonin Reuptake Inhibitors (SSRIs)
    • Dapoxetine
    • Others
    • Phosphodiesterase Type 5 (PDE5) Inhibitors
    • Zertane
    • Others
    • Topical Anesthetics
    • Others
  • By Route of Administration (Revenue, USD Bn, 2021-2033)
    • Oral
    • Topical
  • By Dosage Form (Revenue, USD Bn, 2021-2033)
    • Pills
    • Spray
    • Others
  • By Distribution Channel (Revenue, USD Bn, 2021-2033)
    • Hospitals
    • Online Pharmacies
    • Retail Pharmacies
  • By Region (Revenue, USD Bn, 2021-2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Competitive Landscape
    • Regent Pacific Group Limited
    • Menarini Group
    • Furiex Pharmaceuticals, Inc.
    • Absorption Pharmaceuticals, LLC
    • Ampio Pharmaceuticals, Inc.
    • Aytu BioScience,
    • NeuroHealing Pharmaceuticals Inc.
    • Dong-A Pharmaceutical Co., Ltd.

Table of Contents

1. Research Objective and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Dosage Form
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • PEST Analysis
  • Pipeline Analysis
  • Product Approval
  • Product Launch
  • Collaboration-Acquisition
  • Porter's Five Forces Analysis

4. Global Premature Ejaculation Treatment Market, By Drug Type, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
      • Dapoxetine
      • Others
  • Phosphodiesterase Type 5 (PDE5) Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Segment Trends
      • Zertane
      • Others
  • Topical Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Premature Ejaculation Treatment Market, By Route of Administration, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Premature Ejaculation Treatment Market, By Dosage Form, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Spray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Premature Ejaculation Treatment Market, By Distribution Channel, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Premature Ejaculation Treatment Market, By Region, 2021 - 2033 (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
  • North America
    • Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
      • Central Africa
      • South Africa
      • North Africa
  • Middle East
    • Market Size and Forecast, By Drug Type, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2021 - 2033 (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033 (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Regent Pacific Group Limited
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Menarini Group
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Furiex Pharmaceuticals, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Absorption Pharmaceuticals, LLC
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Ampio Pharmaceuticals, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Aytu BioScience
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • NeuroHealing Pharmaceuticals Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Dong-A Pharmaceutical Co., Ltd.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact